Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI)
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference30 articles.
1. Cancer treatment and survivorship statistics, 2014;DeSantis;CA Cancer J Clin,2014
2. Variation of breast cancer risk among BRCA1/2 carriers;Begg;JAMA,2008
3. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews;Struewing;N Engl J Med,1997
4. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group;Rebbeck;J Clin Oncol,2004
5. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy;Pierce;Breast Cancer Res Treat,2010
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer;Radiotherapy and Oncology;2022-11
2. Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer;Current Breast Cancer Reports;2020-02-17
3. Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI): Erratum;American Journal of Clinical Oncology;2019-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3